Outlook for obesity in 2025: more than a transition year US$ 24.68 Min. order: 1 piece ★★★★★ 4.6 (75 reviews) Sold : Login>>
Novo Nordisk: Investors Focusing On CagriSema Results Are Missing The Big Picture (NVO) US$ 20.65 Min. order: 1 piece ★★★★★ 4.4 (144 reviews) Sold : Login>>
CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment US$ 21.41 Min. order: 1 piece ★★★★★ 4.3 (44 reviews) Sold : Login>>
Chevy Chase GHK-Cu Peptide Therapy US$ 25.97 Min. order: 1 piece ★★★★★ 4.6 (298 reviews) Sold : Login>>
Structural Biophysics-Guided Computational Design of Semaglutide Analogues to Enhance GLP-1R Activation - Article (Preprint v1) by Wei Li US$ 22.81 Min. order: 1 piece ★★★★★ 4.7 (73 reviews) Sold : Login>>